Related Experiment Videos
Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|December 5, 1976
Abstract:
Since November 1974, 44 patients with acute myeloid leukemia, in first remission were randomized between chemotherapy alone and chemotherapy plus BCG. There were 8 relapses and 7 deaths with chemotherapy, 7 relapses and 3 deaths with chemotherapy plus BCG. The survival of both groups is not, at the time, significantly different.